Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Claire S. Philipp"'
Publikováno v:
Thrombosis Update, Vol 14, Iss , Pp 100155- (2024)
Objective: The purpose of our study was to examine risk factors for venous thromboembolism (VTE) and VTE associated mortality in elderly acute lymphocytic leukemia (ALL) patients receiving different treatment options. Methods: We analyzed data from t
Externí odkaz:
https://doaj.org/article/9697a7fc2a804be7897be0f166411ab0
Autor:
Maureen K. Baldwin, Homa K. Ahmadzia, Diane L. Bartlett, Debbie Bensen-Kennedy, Vidhi Desai, Kristina M. Haley, Sherry L. Herman-Hilker, Amanda M. Kilgore, Roshni Kulkarni, Michelle Lavin, Shari Luckey, Kristen A. Matteson, Kristin Paulyson-Nuñez, Claire S. Philipp, Sachiko Ragosta, Kimberly Rosen, Dawn Rotellini, Angela C. Weyand
Publikováno v:
Expert Review of Hematology. 16:71-86
Autor:
Margaret V. Ragni, Scott Rothenberger, Robert Feldman, Danielle Nance, Andrew D Leavitt, Lynn Malec, Robert F. Sidonio, Jr., Eric H. Kraut, Joseph L Lasky, Claire S. Philipp, Dana E. Angelini, Rajiv K. Pruthi, Nina Hwang, Allison P. Wheeler, Roshni Kulkarni, Craig D. Seaman, Frederico Xavier, Nicoletta C Machin, Michael Meyer, Daniel Bellissimo, Kenneth J. Smith, Elizabeth P. Merricks, Timothy C. Nichols, Dana Ivanco, Deborah Vehec, Glory Koerbel, Andrew D. Althouse
Publikováno v:
Blood. 140:1413-1415
Publikováno v:
Blood Coagulation & Fibrinolysis. 32:373-381
Our aim was to evaluate the risk of venous thromboembolism (VTE) with tamoxifen and aromatase inhibitor in older women with breast cancer in the United States. The SEER-Medicare-linked database (2007--2013) was used for women of at least 65 years of
Autor:
Kaan Kavakli, Meriem Belhani, Kirsten Reichwald, Lars Korsholm, Runhui Wu, Hassan M. Yaish, Irina Matytsina, Víctor Jiménez-Yuste, Claire S. Philipp, Tadashi Matsushita
Publikováno v:
Haemophilia
Biblos-e Archivo. Repositorio Institucional de la UAM
Universitat Jaume I
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Biblos-e Archivo. Repositorio Institucional de la UAM
Universitat Jaume I
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Introduction Turoctocog alfa is a recombinant, B domain-truncated factor VIII (FVIII) approved for patients with haemophilia A. Aim To evaluate the safety and efficacy of turoctocog alfa in previously untreated patients (PUPs) with severe haemophilia
Autor:
Paul M. Ness, Maria M. Brooks, Claire S. Philipp, John L. Nosher, Arthur W. Bracey, Jeffrey L. Carson, Lauren Hogshire, Monica B. Pagano, Darrell J. Triulzi, Helaine Noveck
Publikováno v:
TransfusionREFERENCES. 61(7)
BACKGROUND Plasma is frequently administered to patients with prolonged INR prior to invasive procedures. However, there is limited evidence evaluating efficacy and safety. STUDY DESIGN AND METHODS We performed a pilot trial in hospitalized patients
Venous thrombosis and breast cancer in older women: Racial differences in risk factors and mortality
Publikováno v:
Thrombosis Research. 171:130-135
Background Risk factors for venous thromboembolism (VTE) in women with breast cancer are not known by race. Objectives The purpose of our study was to determine risk factors for VTE and VTE associated mortality in white and black women with breast ca
Publikováno v:
Hematology in the Adolescent Female ISBN: 9783030484453
Platelet disorders in the adolescent female are comprised of congenital and acquired platelet disorders associated with a decrease in platelet number and/or abnormality in platelet function. Bleeding symptoms in patients with platelet disorders most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::691ff41fafed695c130b7143c7dc3bf8
https://doi.org/10.1007/978-3-030-48446-0_6
https://doi.org/10.1007/978-3-030-48446-0_6
Autor:
Lynn M. Malec, Nicoletta Machin, Barbara A. Konkle, Craig M. Kessler, Anne T. Neff, Margaret V. Ragni, Andra H. James, Peter A. Kouides, Claire S. Philipp, Craig D. Seaman, Maria M. Brooks
Publikováno v:
Thrombosis Research. 156:8-13
Despite treatment, women with von Willebrand disease (VWD) have lower von Willebrand factor (VWF) levels and greater blood loss at delivery than controls. Current weight-based dosing does not account for the ~1.5-fold increase in blood volume in preg
Publikováno v:
Haemophilia. 23:736-742
INTRODUCTION Family members of Von Willebrand disease (VWD) patients may have low levels of VWF without major bleeding episodes and often remain undiagnosed. AIM The purpose of this study was to assess the utility of a modified Screening Tool in iden